Risk factors of cardiac allograft vasculopathy

Despite advances in prevention and treatment of heart transplant rejection, development of cardiac allograft vasculopathy (CAV) remains the leading factor limiting long-term survival of the graft. Cardiac allograft vasculopathy etiopathogenesis is not fully understood, but a significant role is attr...

Descripción completa

Detalles Bibliográficos
Autores principales: Szyguła-Jurkiewicz, Bożena, Szczurek, Wioletta, Gąsior, Mariusz, Zembala, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735534/
https://www.ncbi.nlm.nih.gov/pubmed/26855649
http://dx.doi.org/10.5114/kitp.2015.56783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735534/
https://www.ncbi.nlm.nih.gov/pubmed/26855649
http://dx.doi.org/10.5114/kitp.2015.56783

Ejemplares similares